Acrivon Therapeutics Inc....
5.59
0.03 (0.54%)
At close: Jan 15, 2025, 2:10 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 36.02M 29.52M 99.60M 1.58M
Short-Term Investments 91.44M 98.23M n/a n/a
Long-Term Investments 414.00K 41.88M 388.00K 407.00K
Other Long-Term Assets 251.00K 4.73M n/a n/a
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 2.23M 4.34M 805.00K 136.00K
Total Current Assets 129.69M 127.75M 100.41M 1.72M
Property-Plant & Equipment 7.91M 6.86M 5.79M 59.00K
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets 8.57M 53.48M 6.18M 466.00K
Total Assets 138.26M 181.23M 106.59M 2.19M
Account Payables 5.05M 904.00K 964.00K 136.00K
Deferred Revenue n/a 69.00K 66.00K n/a
Short-Term Debt 877.00K 1.45M 664.00K 58.00K
Other Current Liabilities 7.38M 4.09M 1.22M 419.00K
Total Current Liabilities 13.30M 6.52M 2.91M 613.00K
Long-Term Debt 3.77M 4.24M 4.96M n/a
Other Long-Term Liabilities n/a n/a 122.52M n/a
Total Long-Term Liabilities 3.77M 4.24M 127.48M 9.98M
Total Liabilities 17.07M 10.75M 130.40M 10.60M
Total Debt 4.64M 4.96M 5.63M 58.00K
Common Stock 23.00K 22.00K 2.00K 1K
Retained Earnings -116.42M -56.03M -24.86M -8.62M
Comprehensive Income -83.00K -95.00K n/a n/a
Shareholders Equity 121.19M 170.47M -23.81M -8.41M
Total Investments 91.86M 140.11M 388.00K 407.00K